HIGH-GRADE SEROUS OVARIAN CARCINOMA

Clinical trials for HIGH-GRADE SEROUS OVARIAN CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HIGH-GRADE SEROUS OVARIAN CARCINOMA trials appear

Sign up with your email to follow new studies for HIGH-GRADE SEROUS OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New drug targets Cancer's 'Extra DNA' in early trial

Disease control Ongoing

This early-phase study tests an experimental oral drug, BBI-355, in people with advanced solid tumors (like certain breast, ovarian, lung, and other cancers) that have extra copies of certain genes (oncogene amplifications). The study aims to find the safest dose and see if BBI-3…

Matched conditions: HIGH-GRADE SEROUS OVARIAN CARCINOMA

Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control

Last updated May 17, 2026 09:21 UTC

HIGH-GRADE SEROUS OVARIAN CARCINOMA

Get alerted when new HIGH-GRADE SEROUS OVARIAN CARCINOMA trials appear

New drug targets Cancer's 'Extra DNA' in early trial